Open AccessEfficacy and safety of third- and fourth-line targeted therapy in japanese patients with metastatic renal cell carcinoma: A retrospective analysis
Author(s) -
Takahito Negishi,
Kei Nagase,
Hidehiro Iwai,
Nobuki Furubayashi,
Kenichi Taguchi,
Motonobu Nakamura
Publication year - 2018
Publication title -
indian journal of urology/indian journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.333
H-Index - 30
eISSN - 1998-3824
pISSN - 0970-1591
DOI - 10.4103/iju.iju_248_17
Subject(s) - medicine , renal cell carcinoma , oncology , retrospective cohort study , targeted therapy , cancer
There is limited data on the efficacy of sequential targeted therapy for metastatic renal cell carcinoma (mRCC) beyond the second line, especially for Asian patients. We evaluated the efficacy and side effects of targeted therapy beyond the second line.